Pagsuri ng sanggunian at mahalagang pagwawasto: 2026-10-06.
Hipotetikal na sitwasyon, hindi napatunayang kliyente, tagal, FSVP audit o resulta. Dates dito ay prutas. FDA Q&A nagsasabing inaccurate notice ang number na hindi tugma sa tunay na manufacturer. Confirmation ay received for review, hindi accuracy/timeliness/release. Error/delay maaaring refusal/hold, hindi awtomatikong lahat ng lumang shipment.
Pag-ayos ng future template hindi retroactive edit ng confirmed notice. PNSI draft maaaring baguhin bago submit; limited FDA-requested correction bago confirmation hindi general right. 21 CFR 1.282 kailangan resubmit ng nagbagong required data, maliban quantity/arrival/planned shipment; mail: planned mailing date. Manufacturer number hindi exception, ibang kondisyon kung hindi iimport. Dapat ayon rekomendasyon cancel old PNSI doon, ACE via CBP request cancel entry. Itago ebidensiya: new confirmation karaniwang 2 h road, 4 rail/air, 8 water, mail before sending. Pagdating/refusal sundin FDA/CBP, walang pangakong retroactive cure.
21 CFR 1.281 hiwalay manufacturer ng di-natural state food at known grower/allowed consolidator. Pangalan plus number/city/country o full address/reason no number ayon rule. Illustrative worksheet: product/code/state, verified manufacturer/grower, entry, quantity/lot kung required, countries, parties/transport/arrival/mail, prior refusal country kung required, reviewer/source/date, confirmation/cancel/replacement. FDA mandatory/conditional fields iba sa broker extras; DUNS/UFI at US Agent hindi universal. Authorized necessary data lamang, walang password/account/PIN sa shipment/public. Renewal Oktubre–Disyembre 2026 hiwalay, FDA zero, professional separate, walang guarantee.
Huwag kailanman ibahagi ang FIS-FURLS username o password sa sinuman.
https://fdabridge.com/fil/makipag-ugnayan